Stay updated on ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study page shows an updated revision label from v3.6.5 to v3.6.6, indicating a small documentation update.
    Difference
    0.1%
    Check dated 2026-08-29T23:51:27.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision line now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a newly published revision in the site’s version history.
    Difference
    0.1%
    Check dated 2026-08-08T22:31:29.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.3 to v3.6.4. This indicates a maintenance update to the page's template and metadata rather than to its visible content.
    Difference
    0.1%
    Check dated 2026-07-25T13:00:50.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a small release update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:36.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a backend/template update applied to the study page rather than a change to the clinical trial data.
    Difference
    0.1%
    Check dated 2026-06-26T22:26:49.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added new help/navigation sections: How to Read a Study Record, Common Questions, and How to Join a Study, and standardized the Intervention/Treatment heading. The previous revision note Revision: v3.5.5 was removed and replaced with Revision: v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T12:20:35.000Z thumbnail image

Stay in the know with updates to ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ECT-Pembrolizumab for Unresectable Melanoma Clinical Trial page.